
Macquarie downgrades Boss Energy (BQSSF) to a Hold
Don't Miss TipRanks' Half-Year Sale
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
In addition to Macquarie, Boss Energy also received a Hold from Jefferies's Daniel Roden in a report issued on July 2. However, on the same day, J.P. Morgan maintained a Buy rating on Boss Energy (Other OTC: BQSSF).
The company has a one-year high of $3.11 and a one-year low of $1.26. Currently, Boss Energy has an average volume of 25.78K.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 hours ago
- Yahoo
What US dollar weakness says about American exceptionalism
The dollar (DX=F, has had a 13-year run, but that era may be ending. Thierry Wizman, Macquarie Global FX and interest rates strategist, joins Market Catalysts to explain why the currency could be entering a period of weakness tied to rich valuations, policy uncertainty, and shifting global demand. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts here. I mean, of course it's natural for most assets to go up and down. Um, but I I don't know if we have yet seen this kind of a move in the dollar that implies what this perhaps implies about American exceptionalism. I'm curious your take on whether American exceptionalism has indeed really taken a hit or are there other aspects going on here? Thanks for having me, Julie. Look, I you know, it's interesting because the dollar, uh, the dollar strength, the US dollar strength was not really something that prevailed only in the back half of 2024. Uh, the dollar has been a strong currency for the past 13 years. It's been generally increasing or rallying or appreciating against other currencies both in nominal terms and real terms since 2001. So if you're going to talk about American exceptionalism as being somewhat equivalent to, uh, the appreciation of the US dollar, the strength of the US dollar, effectively we've had American exceptionalism for 13 years. And and if you point to the headlines of course in the history of these last 13 years, it it certainly does seem to support the idea that American exceptionalism has been around that long. We've had a lot of economic, small economic revolutions in this country that have, uh, produced productivity, uh, uh, produced growth, um, and it's been superlative effectively, uh, at least the way the market has interpreted relative to what has been going on in other countries over this 13-year period. So American exceptionalism has been going on for 13 years. Now the question is, are we at a point where after 13 years of this, uh, we are going to start to go in reverse. I think to some extent we are. One reason is that these periods of American exceptionalism that are matched by dollar strength don't usually last more than about a decade. So we're kind of overdue for a return. Uh, the other issue of course is that we've gone in these 13 years to a point in which US asset values and the value of the dollar has gotten very rich, objectively speaking, if you just look at these long-term charts. That's another reason. And of course with the a change of the administration and with the policy uncertainty that has come with it in the last, uh, few weeks and months, there now is a, you know, a compelling reason for asset allocators abroad to start, uh, winding down or dialing back their dollar exposure, both their US asset exposure and the attached dollar exposure. And I think those three things, you know, working together are what's going to, uh, cause the dollar at least to go into, I wouldn't call it a tail spin, but certainly a period of weakness here. So I don't think that we are going to get back to these highs that you alluded to earlier that prevailed in the very beginning of this year, uh, before this this down move. I think that's a thing of the past and I think that is the dollar is going to be weighed down by a few factors going forward, and it could last a few years. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Business Insider
12 hours ago
- Business Insider
Citi Keeps Their Buy Rating on Inmobiliaria Colonial (0RID)
In a report released today, Aaron Guy from Citi maintained a Buy rating on Inmobiliaria Colonial, with a price target of €7.50. The company's shares closed last Friday at €5.95. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Guy covers the Real Estate sector, focusing on stocks such as Derwent London plc REIT, Safestore Holdings, and Inmobiliaria Colonial. According to TipRanks, Guy has an average return of -0.3% and a 54.55% success rate on recommended stocks. Currently, the analyst consensus on Inmobiliaria Colonial is a Hold with an average price target of €6.15.


Business Insider
13 hours ago
- Business Insider
Goldman Sachs Remains a Buy on Argenx Se (ARGX)
In a report released on July 4, Richard Felton from Goldman Sachs maintained a Buy rating on Argenx Se, with a price target of $835.00. The company's shares closed last Thursday at $543.48. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Felton is a 4-star analyst with an average return of 10.2% and a 64.84% success rate. Felton covers the Healthcare sector, focusing on stocks such as Carl Zeiss Meditec, Fresenius Medical Care AG & Co. KGaA, and Fresenius SE & Co. KGaA. Argenx Se has an analyst consensus of Strong Buy, with a price target consensus of $754.09, a 38.75% upside from current levels. In a report released on July 2, Morgan Stanley also initiated coverage with a Buy rating on the stock with a $700.00 price target.